David A. Moreno
39Patents
6h-index
85Co-inventors
68Inventor score
Filing activity: Feb 27, 2009 → Jun 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10208024B2 | 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases | Physics | 27 | Active |
| US8697715B2 | Serine/threonine kinase inhibitors | Chemistry; Metallurgy | 18 | Active |
| US10112942B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 14 | Active |
| US10172851B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US10137124B2 | Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US9187462B2 | Substituted quinazolines as serine/threonine kinase inhibitors | Chemistry; Metallurgy | 6 | Active |
| US8394795B2 | Pyrazole [3, 4-B] pyridine Raf inhibitors | Chemistry; Metallurgy | 5 | Active |
| US9763942B2 | Serine/threonine kinase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US9259470B2 | Serine/threonine kinase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US10144734B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US11414404B2 | Compounds for the treatment of BRAF-associated diseases and disorders | Human Necessities | 4 | Active |
| US10555944B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 4 | Active |
| US9708290B2 | Serine/threonine kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US9670208B2 | Serine/threonine kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10154995B2 | Serine/threonine kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10172845B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10881652B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US8338452B2 | Raf inhibitor compounds and methods of use thereof | Chemistry; Metallurgy | 1 | Active |
| US10745419B2 | Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile | Chemistry; Metallurgy | 1 | Active |
| US10953005B1 | Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11802127B2 | 3,4-dihydro-2,7-naphthyridine-1,6(2H,7H)-diones as MEK inhibitors | Human Necessities | 0 | Active |
| US11098064B2 | Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile | Chemistry; Metallurgy | 0 | Active |
| US11851434B2 | Substituted pyrazolo[1,5-A]pyrazine compounds as ret kinase inhibitors | Human Necessities | 0 | Active |
| US11472802B2 | Substituted pyrazolyl[4,3-c]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10441581B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.